• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体疫苗在下呼吸道病毒感染中的近期应用简述:从流感疫苗到新冠疫苗

Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines.

作者信息

Attia Mohamed Ahmed, Essa Ebtessam Ahmed, Elebyary Toka Tarek, Faheem Ahmed Mostafa, Elkordy Amal Ali

机构信息

School of Pharmacy and Pharmaceutical Sciences, Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland SR1 3SD, UK.

Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta 31511, Egypt.

出版信息

Pharmaceuticals (Basel). 2021 Nov 17;14(11):1173. doi: 10.3390/ph14111173.

DOI:10.3390/ph14111173
PMID:34832955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8619292/
Abstract

Vaccination is the most effective means of preventing infectious diseases and saving lives. Modern biotechnology largely enabled vaccine development. In the meantime, recent advances in pharmaceutical technology have resulted in the emergence of nanoparticles that are extensively investigated as promising miniaturized drug delivery systems. Scientists are particularly interested in liposomes as an important carrier for vaccine development. Wide acceptability of liposomes lies in their flexibility and versatility. Due to their unique vesicular structure with alternating aqueous and lipid compartments, liposomes can enclose both hydrophilic and lipophilic compounds, including antigens. Liposome composition can be tailored to obtain the desired immune response and adjuvant characteristics. During the current pandemic of COVID-19, many liposome-based vaccines have been developed with great success. This review covers a liposome-based vaccine designed particularly to combat viral infection of the lower respiratory tract (LRT), i.e., infection of the lung, specifically in the lower airways. Viruses such as influenza, respiratory syncytial virus (RSV), severe acute respiratory syndrome (SARS-CoV-1 and SARS-CoV-2) are common causes of LRT infections, hence this review mainly focuses on this category of viruses.

摘要

疫苗接种是预防传染病和拯救生命的最有效手段。现代生物技术在很大程度上推动了疫苗的研发。与此同时,制药技术的最新进展导致了纳米颗粒的出现,作为有前景的小型化药物递送系统,纳米颗粒受到了广泛研究。科学家们对脂质体作为疫苗研发的重要载体尤为感兴趣。脂质体的广泛可接受性在于其灵活性和多功能性。由于其独特的囊泡结构,具有交替的水相和脂质相区室,脂质体可以包裹亲水性和亲脂性化合物,包括抗原。可以对脂质体的组成进行定制,以获得所需的免疫反应和佐剂特性。在当前新冠疫情期间,许多基于脂质体的疫苗已成功研发出来。本综述涵盖了一种特别设计用于对抗下呼吸道(LRT)病毒感染,即肺部感染,特别是下气道感染的基于脂质体的疫苗。流感、呼吸道合胞病毒(RSV)、严重急性呼吸综合征(SARS-CoV-1和SARS-CoV-2)等病毒是下呼吸道感染的常见病因,因此本综述主要关注这类病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6722/8619292/93ddc3dff152/pharmaceuticals-14-01173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6722/8619292/2d8d6a9e8e63/pharmaceuticals-14-01173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6722/8619292/57bf43a63587/pharmaceuticals-14-01173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6722/8619292/93ddc3dff152/pharmaceuticals-14-01173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6722/8619292/2d8d6a9e8e63/pharmaceuticals-14-01173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6722/8619292/57bf43a63587/pharmaceuticals-14-01173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6722/8619292/93ddc3dff152/pharmaceuticals-14-01173-g003.jpg

相似文献

1
Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines.脂质体疫苗在下呼吸道病毒感染中的近期应用简述:从流感疫苗到新冠疫苗
Pharmaceuticals (Basel). 2021 Nov 17;14(11):1173. doi: 10.3390/ph14111173.
2
Liposomes as vaccine delivery systems: a review of the recent advances.脂质体作为疫苗递送系统:近期进展综述
Ther Adv Vaccines. 2014 Nov;2(6):159-82. doi: 10.1177/2051013614541440.
3
Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021.呼吸道病毒监测在急性呼吸道疾病患儿中的应用——新疫苗监测网络,美国,2016-2021 年。
MMWR Morb Mortal Wkly Rep. 2022 Oct 7;71(40):1253-1259. doi: 10.15585/mmwr.mm7140a1.
4
Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaoundé, Cameroon, 2020-2021.2020-2021 年在喀麦隆雅温得,疑似 COVID-19 大流行期间急性和严重呼吸道感染中人类呼吸道合胞病毒的合并感染。
Influenza Other Respir Viruses. 2023 Mar;17(3):e13131. doi: 10.1111/irv.13131.
5
Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.颠覆传统:聚合物纳米颗粒链接疫苗直击呼吸道病毒
Life Sci. 2021 Sep 1;280:119744. doi: 10.1016/j.lfs.2021.119744. Epub 2021 Jun 24.
6
Liposomes: a promising carrier for respiratory syncytial virus therapeutics.脂质体:一种有前途的呼吸道合胞病毒治疗载体。
Expert Opin Drug Deliv. 2019 Sep;16(9):969-980. doi: 10.1080/17425247.2019.1652268. Epub 2019 Aug 7.
7
Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs.基于脂质纳米颗粒的保守肽流感疫苗和单钠尿酸盐晶体佐剂在猪中引发保护性免疫应答。
Int J Nanomedicine. 2018 Oct 24;13:6699-6715. doi: 10.2147/IJN.S178809. eCollection 2018.
8
Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans.使用来自耐辐射球菌的免疫原性脂质的脂质体包裹重组呼吸道合胞病毒(RSV)疫苗增强免疫保护作用。
Vaccine. 2002 Feb 22;20(11-12):1586-92. doi: 10.1016/s0264-410x(01)00487-x.
9
The disappearance of respiratory syncytial virus and influenza viruses in children during the second year of the COVID-19 pandemic - are non-pharmaceutical interventions as effective as vaccines?在 COVID-19 大流行的第二年,儿童体内呼吸道合胞病毒和流感病毒消失——非药物干预措施是否像疫苗一样有效?
Eur Rev Med Pharmacol Sci. 2023 Apr;27(8):3777-3783. doi: 10.26355/eurrev_202304_32178.
10
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.基于脂质的纳米颗粒用于疫苗佐剂和抗原的传递:迈向多组分疫苗。
Mol Pharm. 2021 Aug 2;18(8):2867-2888. doi: 10.1021/acs.molpharmaceut.1c00447. Epub 2021 Jul 15.

引用本文的文献

1
[Research advances of liposomes and exosomes in drug delivery and biomarker screening].脂质体与外泌体在药物递送和生物标志物筛选中的研究进展
Se Pu. 2025 May;43(5):472-486. doi: 10.3724/SP.J.1123.2024.08012.
2
Toward a cure for type 1 diabetes: the innovative potential of Phosphatidylserine-rich liposomes.迈向1型糖尿病的治愈:富含磷脂酰丝氨酸脂质体的创新潜力。
Nanomedicine (Lond). 2025 May;20(10):1077-1079. doi: 10.1080/17435889.2025.2473872. Epub 2025 Feb 28.
3
Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery.

本文引用的文献

1
Subunit Nanovaccine with Potent Cellular and Mucosal Immunity for COVID-19.用于COVID-19的具有强大细胞免疫和黏膜免疫的亚单位纳米疫苗。
ACS Appl Bio Mater. 2020 Sep 21;3(9):5633-5638. doi: 10.1021/acsabm.0c00668. Epub 2020 Aug 26.
2
Lipid nanoparticles for mRNA delivery.用于mRNA递送的脂质纳米颗粒。
Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10.
3
The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2.针对 SARS-CoV-2 经多种途径给予脂质体包封的 mRNA 疫苗的研究。
变革医学:纳米材料在药物递送中的前沿应用
ACS Nano. 2025 Feb 4;19(4):4011-4038. doi: 10.1021/acsnano.4c09566. Epub 2025 Jan 17.
4
Liposomes and Their Therapeutic Applications in Enhancing Psoriasis and Breast Cancer Treatments.脂质体及其在增强银屑病和乳腺癌治疗中的治疗应用。
Nanomaterials (Basel). 2024 Nov 1;14(21):1760. doi: 10.3390/nano14211760.
5
Excessive lipid production shapes glioma tumor microenvironment.过量脂质产生塑造了胶质瘤肿瘤微环境。
Ultrastruct Pathol. 2024 Sep 2;48(5):367-377. doi: 10.1080/01913123.2024.2392728. Epub 2024 Aug 19.
6
Single-nanoparticle electrophoretic mobility determination and trapping using active-feedback 3D tracking.利用主动反馈三维跟踪技术测定和捕获单纳米颗粒的电泳迁移率
bioRxiv. 2024 Aug 4:2024.07.08.602591. doi: 10.1101/2024.07.08.602591.
7
Lipid-Based Nanotechnology: Liposome.基于脂质的纳米技术:脂质体。
Pharmaceutics. 2023 Dec 26;16(1):34. doi: 10.3390/pharmaceutics16010034.
8
Excessive Lipid Production Shapes Glioma Tumor Microenvironment.脂质过度生成塑造胶质瘤肿瘤微环境。
Res Sq. 2023 Dec 12:rs.3.rs-3694185. doi: 10.21203/rs.3.rs-3694185/v1.
9
Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations.疫苗佐剂的进展:从明矾到纳米制剂的历程
Vaccines (Basel). 2023 Nov 9;11(11):1704. doi: 10.3390/vaccines11111704.
10
Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants.非侵入性疫苗:制剂和疫苗佐剂方面的挑战
Pharmaceutics. 2023 Aug 9;15(8):2114. doi: 10.3390/pharmaceutics15082114.
J Control Release. 2021 Jul 10;335:449-456. doi: 10.1016/j.jconrel.2021.05.024. Epub 2021 May 21.
4
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines.临床及临床试验中的脂质纳米颗粒:从癌症纳米医学到新冠疫苗
Vaccines (Basel). 2021 Apr 8;9(4):359. doi: 10.3390/vaccines9040359.
5
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.mRNA-脂质纳米颗粒 COVID-19 疫苗:结构与稳定性。
Int J Pharm. 2021 May 15;601:120586. doi: 10.1016/j.ijpharm.2021.120586. Epub 2021 Apr 9.
6
The dawn of mRNA vaccines: The COVID-19 case.mRNA 疫苗的黎明:COVID-19 案例。
J Control Release. 2021 May 10;333:511-520. doi: 10.1016/j.jconrel.2021.03.043. Epub 2021 Mar 30.
7
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.临床认可基于纳米技术的 SARS-CoV-2 mRNA 疫苗:对转化纳米医学的影响。
Drug Deliv Transl Res. 2021 Aug;11(4):1309-1315. doi: 10.1007/s13346-021-00911-y. Epub 2021 Jan 29.
8
Current State of the First COVID-19 Vaccines.首批新冠疫苗的现状
Vaccines (Basel). 2021 Jan 8;9(1):30. doi: 10.3390/vaccines9010030.
9
Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences.对新冠疫苗的严重过敏反应——声明及实际影响
Allergol Select. 2021 Jan 5;5:26-28. doi: 10.5414/ALX02215E. eCollection 2021.
10
Non-viral COVID-19 vaccine delivery systems.非病毒 COVID-19 疫苗传递系统。
Adv Drug Deliv Rev. 2021 Feb;169:137-151. doi: 10.1016/j.addr.2020.12.008. Epub 2020 Dec 17.